Hostname: page-component-7c8c6479df-ph5wq Total loading time: 0 Render date: 2024-03-27T01:40:08.094Z Has data issue: false hasContentIssue false

Home treatment service

Published online by Cambridge University Press:  02 January 2018

MacDara McCauley*
Affiliation:
Cavan/Monaghan Psychiatric Services
Rights & Permissions [Opens in a new window]

Abstract

Type
The Columns
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Royal College of Psychiatrists, 2002

Sir: I would like to respond to the concerns raised by Sandor (Psychiatric Bulletin, December 2001, 25, 486-487) regarding home treatment. He is correct to highlight the lack of a ‘strong evidenced-based rationale’. However, his focus on ‘model fidelity’ is, in my view, misplaced.

It is tempting to fault models of service delivery on this basis, but surely this ignores more important issues? Instead we should focus on the important factors like patients' clinical and social outcomes. Other factors like service retention, adherence and satisfaction levels should also be borne in mind.

To suggest that an identikit model can be used in vastly different settings seems unrealistic. This creates a problem insofar as it acknowledges that model fidelity is an improbable goal. None the less, I would refer Sandor to the editorial by Slade & Priebe (Reference Slade and Priebe2001), ‘the challenge is to make the important measurable’. We could see this as following the lead of naturalistic pharmacological research (i.e. examining real-life scenarios).

Therefore, I would suggest that those assessing the impact of home treatment should acknowledge the deficiencies as outlined by Sandor. But it is imperative that we embrace the challenge to measure what is important.

References

Slade, M. & Priebe, S. (2001) Are randomised controlled trials the only gold that glitters? British Journal of Psychiatry, 179, 286287.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.